RNA technology takes on diabetes: first human trial of exenatide nanoparticle injection
NCT ID NCT07347080
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial is testing a single dose of a new type of exenatide injection (CR059) in 9 Chinese adults with type 2 diabetes. The exenatide is delivered using circular RNA wrapped in lipid nanoparticles, a technology similar to some vaccines. The main goal is to check safety and tolerability, while also looking at how the drug moves through the body and affects blood sugar. Because it's a very small, first-in-human study, it's mainly about gathering initial safety data.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- exenatide circular RNA-lipid nanoparticle injection (CR059)
- What this could lead to
- If it works, this could lead to a new way to deliver exenatide for better blood sugar control in type 2 diabetes.
- What could go wrong
- This is a very early, small trial with only 9 people, so it may not show clear benefits or could have unexpected side effects. Success is far from guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Henan University of Science and Technology
RECRUITINGLuoyang, Henan, 310015, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New diabetes pill HRS9531 enters Mid-Stage trial – could it help control blood sugar?
- New diabetes drug HM15275 enters Mid-Stage trial
- Sleep and menopause may harm diabetic women's hearts, study warns
- Could this pill protect kidneys in diabetes?
- Talking to your phone could detect diabetes, study finds
- Could a simple calcium infusion help tame blood sugar?